Refrex-1, a soluble restriction factor against feline endogenous and exogenous retroviruses

Journal of Virology

Volumn 87, Issue 22, 2013, Pages 12029-12040

  Ito, Jumpei ^a   Watanabe, Shinya ^a   Hiratsuka, Takahiro ^a   Kuse, Kyohei ^a   Odahara, Yuka ^a   Ochi, Haruyo ^a   Kawamura, Maki ^a   Nishigaki, Kazuo ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RESTRICTION FOR FELINE RETROVIRUS X 1; SOLUBLE ANTIRETROVIRAL FACTOR; UNCLASSIFIED DRUG; VIRUS RECEPTOR; ANTIRETROVIRUS AGENT; MESSENGER RNA; PEPTIDE FRAGMENT; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENVELOPE GENE; FELINE ENDOGENOUS GAMMARETROVIRUS OF THE DOMESTIC CAT; FELINE LEUKEMIA VIRUS; FELINE LEUKEMIA VIRUS SUBGROUP D; FEMALE; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; VIRUS GENE; VIRUS INTERFERENCE; VIRUS REPLICATION; VIRUS STRAIN; AMINO ACID SEQUENCE; ANIMAL; CAT; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; PATHOGENICITY; PHYSIOLOGY; PROVIRUS; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRIDAE INFECTIONS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TUMOR VIRUS INFECTIONS; VETERINARY; VIROLOGY; WESTERN BLOTTING;

FELIDAE; FELINE LEUKEMIA VIRUS; FELIS CATUS; GAMMARETROVIRUS; REPLICATION COMPETENT VIRUSES;

AMINO ACID SEQUENCE; ANIMALS; ANTI-RETROVIRAL AGENTS; BLOTTING, WESTERN; CATS; CLONING, MOLECULAR; FEMALE; GENE PRODUCTS, ENV; GENES, ENV; HUMANS; IMMUNOPRECIPITATION; LEUKEMIA VIRUS, FELINE; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROVIRUSES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, VIRUS; RETROVIRIDAE INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR VIRUS INFECTIONS; VIRAL INTERFERENCE; VIRUS REPLICATION;

EID: 84886259598     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01267-13     Document Type: Article

References (51)

1. Hisasue M, Nagashima N, Nishigaki K, Fukuzawa I, Ura S, Katae H, Tsuchiya R, Yamada T, Hasegawa A, Tsujimoto H. 2009. Myelodysplastic syndromes and acute myeloid leukemia in cats infected with feline leukemia virus clone33 containing a unique long terminal repeat. Int. J. Cancer 124:1133-1141.
2. Hartmann K. 2011. Clinical aspects of feline immunodeficiency and feline leukemia virus infection. Vet. Immunol. Immunopathol. 143:190-201.
3. Overbaugh J, Miller AD, Eiden MV. 2001. Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiol. Mol. Biol. Rev. 65:371-389.
4. Quigley JG, Burns CC, Anderson MM, Lynch ED, Sabo KM, Overbaugh J, Abkowitz JL. 2000. Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia. Blood 95:1093-1099.
5. Tailor CS, Willett BJ, Kabat D. 1999. A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily. J. Virol. 73:6500-6505.
6. Mendoza R, Anderson MM, Overbaugh J. 2006. A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A. J. Virol. 80:3378-3385.
7. Takeuchi Y, Vile RG, Simpson G, O'Hara B, Collins MK, Weiss RA. 1992. Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. J. Virol. 66:1219-1222.
8. Shalev Z, Duffy SP, Adema KW, Prasad R, Hussain N, Willett BJ, Tailor CS. 2009. Identification of a feline leukemia virus variant that can use THTR1, FLVCR1, and FLVCR2 for infection. J. Virol. 83:6706-6716.
9. Anderson MM, Lauring AS, Burns CC, Overbaugh J. 2000. Identification of a cellular cofactor required for infection by feline leukemia virus. Science 287:1828-1830.
10. Anai Y, Ochi H, Watanabe S, Nakagawa S, Kawamura M, Gojobori T, Nishigaki K. 2012. Infectious endogenous retroviruses in cats and emergence of recombinant viruses. J. Virol. 86:8634-8644.
11. Overbaugh J, Riedel N, Hoover EA, Mullins JI. 1988. Transduction of endogenous envelope genes by feline leukaemia virus in vitro. Nature 332:731-734.
12. Watanabe S, Kawamura M, Odahara Y, Anai Y, Ochi H, Nakagawa S, Endo Y, Tsujimoto H, Nishigaki K. 2013. Phylogenetic and structural diversity in the feline leukemia virus env gene. PLoS One 8:e61009. doi:10.1371/journal.pone.0061009.
13. Rigby MA, Rojko JL, Stewart MA, Kociba GJ, Cheney CM, Rezanka LJ, Mathes LE, Hartke JR, Jarrett O, Neil JC. 1992. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. J. Gen. Virol. 73:2839-2847.
14. Boeke JD, Stoye JP. 1997. Retrotransposons, endogenous retroviruses, and the evolution of retroelements, p343-436. In Coffin JM, Hughes SH, Varmus HE (ed), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
15. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
16. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M, Bray N, Brent MR, Brown DG, Brown SD, Bult C, Burton J, Butler J, Campbell RD, Carninci P, Cawley S, Chiaromonte F, Chinwalla AT, Church DM, Clamp M, Clee C, Collins FS, Cook LL, Copley RR, Coulson A, Couronne O, CuffJ, Curwen V, Cutts T, Daly M, David R, Davies J, Delehaunty KD, Deri J, Dermitzakis ET, Dewey C, Dickens NJ, Diekhans M, Dodge S, Dubchak I, Dunn DM, Eddy SR, Elnitski L, Emes RD, Eswara P, Eyras E, Felsenfeld A, Fewell GA, Flicek P, Foley K, Frankel WN, Fulton LA, Fulton RS, Furey TS, Gage D, Gibbs RA, Glusman G, Gnerre S, et al. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520-562.
17. Feschotte C, Gilbert C. 2012. Endogenous viruses: insights into viral evolution and impact on host biology. Nat. Rev. Genet. 13:283-296.
18. Nethe M, Berkhout B, van der Kuyl AC. 2005. Retroviral superinfection resistance. Retrovirology 2:52.
19. Ikeda H, Odaka T. 1983. Cellular expression of murine leukemia virus gp70-related antigen on thymocytes of uninfected mice correlates with Fv-4 gene-controlled resistance to Friend leukemia virus infection. Virology 128:127-139.
20. Ikeda H, Laigret F, Martin MA, Repaske R. 1985. Characterization of a molecularly cloned retroviral sequence associated with Fv-4 resistance. J. Virol. 55:768-777.
21. Munk C, Beck T, Zielonka J, Hotz-Wagenblatt A, Chareza S, Battenberg M, Thielebein J, Cichutek K, Bravo IG, O'Brien SJ, Lochelt M, Yuhki N. 2008. Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol. 9:R48.
22. Dietrich I, McMonagle EL, Petit SJ, Vijayakrishnan S, Logan N, Chan CN, Towers GJ, Hosie MJ, Willett BJ. 2011. Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection. J. Virol. 85:5840-5852.
23. Fukuma A, Abe M, Morikawa Y, Miyazawa T, Yasuda J. 2011. Cloning and characterization of the antiviral activity of feline Tetherin/BST-2. PLoS One 6:e18247. doi:10.1371/journal.pone.0018247.
24. McEwan WA, Schaller T, Ylinen LM, Hosie MJ, Towers GJ, Willett BJ. 2009. Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat. J. Virol. 83:8270-8275.
25. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
26. Kim CH, Oh Y, Lee TH. 1997. Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells. Gene 199: 293-301.
27. Jainchill JL, Aaronson SA, Todaro GJ. 1969. Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4:549-553.
28. Unkeless JC. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580-596.
29. Snyder HW, Jr, Hardy WD, Jr, Zuckerman EE, Fleissner E. 1978. Characterisation of a tumour-specific antigen on the surface of feline lymphosarcoma cells. Nature 275:656-658.
30. Rasheed S, Gardner MB. 1980. Characterization of cat cell cultures for expression of retrovirus, FOCMA and endogenous sarc genes, p 393-400. In Hardy WD, Jr, Essex M, McClelland AJ. (ed), Proceedings of the third international feline leukemia virus meeting. Elsevier/North-Holland Publishing Co, New York, NY.
31. Muleya JS, Nakaichi M, Sugahara J, Taura Y, Murata T, Nakama S. 1998. Establishment and characterization of a new cell line derived from feline mammary tumor. J. Vet. Med. Sci. 60:931-935.
32. Crandell RA, Fabricant CG, Nelson-Rees WA. 1973. Development, characterization, and viral susceptibility of a feline (Felis catus) renal cell line (CRFK). In Vitro 9:176-185.
33. Mochizuki H, Takahashi M, Nishigaki K, Ide T, Goto-Koshino Y, Watanabe S, Sato H, Sato M, Kotera Y, Fujino Y, Ohno K, Uchida K, Tsujimoto H. 2011. Establishment of a novel feline leukemia virus (FeLV)-negative B-cell cell line from a cat with B-cell lymphoma. Vet. Immunol. Immunopathol. 140:307-311.
34. Stewart MA, Warnock M, Wheeler A, Wilkie N, Mullins JI, Onions DE, Neil JC. 1986. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J. Virol. 58:825-834.
35. Nishigaki K, Hanson C, Thompson D, Yugawa T, Hisasue M, Tsujimoto H, Ruscetti S. 2002. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus. J. Virol. 76: 1527-1532.
36. Nunberg JH, Williams ME, Innis MA. 1984. Nucleotide sequences of the envelope genes of two isolates of feline leukemia virus subgroup B. J. Virol. 49:629-632.
37. Riedel N, Hoover EA, Gasper PW, Nicolson MO, Mullins JI. 1986. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. J. Virol. 60:242-250.
38. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. CLUSTALWand CLUSTAL X version 2.0. Bioinformatics 23:2947-2948.
39. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
40. Kimura M. 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16:111-120.
41. Schwarz G. 1978. Estimating the dimension of a model. Ann. Stat. 6:461-464.
42. Kumar S, Nei M, Dudley J, Tamura K. 2008. MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief. Bioinformatics 9:299-306.
43. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum-parsimony methods. Mol. Biol. Evol. 28:2731-2739.
44. Heard JM, Danos O. 1991. An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J. Virol. 65:4026-4032.
45. Battini JL, Heard JM, Danos O. 1992. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J. Virol. 66:1468-1475.
46. McDougall AS, Terry A, Tzavaras T, Cheney C, Rojko J, Neil JC. 1994. Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses. J. Virol. 68:2151-2160.
47. Barnett AL, Wensel DL, Li W, Fass D, Cunningham JM. 2003. Structure and mechanism of a coreceptor for infection by a pathogenic feline retrovirus. J. Virol. 77:2717-2729.
48. Jung YT, Lyu MS, Buckler-White A, Kozak CA. 2002. Characterization of a polytropic murine leukemia virus proviral sequence associated with the virus resistance gene Rmcf of DBA/2 mice. J. Virol. 76:8218-8224.
49. Wu T, Yan Y, Kozak CA. 2005. Rmcf2, a xenotropic provirus in the Asian mouse species Mus castaneus, blocks infection by polytropic mouse gammaretroviruses. J. Virol. 79:9677-9684.
50. Mendoza R, Miller AD, Overbaugh J. 2013. Disruption of thiamine uptake and growth of cells by feline leukemia virus subgroup A. J. Virol. 87:2412-2419.
51. Quigley JG, Yang Z, Worthington MT, Phillips JD, Sabo KM, Sabath DE, Berg CL, Sassa S, Wood BL, Abkowitz JL. 2004. Identification of a human heme exporter that is essential for erythropoiesis. Cell 118:757-766.